Scientist, In Vivo Pharmacology, Inflammation Research

Responsibilities

• Execute in vivo preclinical disease models and in vitro assays to support pipeline programs in inflammation research
• Perform hands-on in vivo work primarily with mice and potentially rats
• Design experiments and execute studies in collaboration with senior and associate scientists
• Generate high-quality experimental data and ensure studies are organized and prepared
• Supervise and coordinate tasks for associate scientists to ensure successful study execution
• Analyze and communicate research results to project teams and the broader department
• Contribute to project progression by applying a deep understanding of the underlying biology

Requirements

• Doctorate degree OR Master's degree with 2 years of experience OR Bachelor's degree with 4 years of experience
• Experience in Immunology or related scientific disciplines
• Proven experience in in vivo preclinical disease model execution
• Proficiency with GraphPad Prism and Microsoft Excel
• Hands-on experience with in vivo dosing and necropsy techniques

Preferred Qualifications

• PhD with post-doctoral training or drug discovery experience in Immunology, inflammation, or autoimmune disease
• Experience with respiratory disease models (asthma, COPD, fibrosis) or inflammatory models (colitis, lupus, RA)
• Expertise in lung function measurements, imaging, and inhaled drug delivery
• Proficiency in cellular, biochemical, and molecular biology assays such as ELISA, MSD, and flow cytometry
• Demonstrated track record of independent critical thinking and scientific achievement

Benefits

• Comprehensive medical, dental, and vision coverage
• Retirement and Savings Plan with company contributions
• Discretionary annual bonus program
• Stock-based long-term incentives
• Award-winning time-off plans

About the Company

Amgen is a leading biotechnology company dedicated to serving patients living with serious illnesses. Since 1980, Amgen has pioneered advancements in oncology, inflammation, general medicine, and rare diseases, leveraging human genetics and biologics manufacturing to deliver innovative medicines worldwide.